Status | Study |
Recruiting |
Study Name: A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD Condition: Graft Versus Host Disease Date: 2016-10-24 Interventions: Biological: GLASSIA Other Name |
Recruiting |
Study Name: A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease Condition: Graft vs Host Disease Date: 2016-10-03 Interventions: Biological: Mesenchymoangioblast-derived mesenchymal stem cells The active agent in CYP-001 is allogenei |
Recruiting |
Study Name: MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease Condition: Acute GVH Disease Date: 2016-09-21 Interventions: Other: Peripheral Venipuncture or Blood draw from Central Line Other Names: |
Recruiting |
Study Name: Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD Condition: Peripheral Blood Stem Cell Transplantation aGVHD Date: 2016-07-26 Interventions: Drug: VPA Valproic acid with 1000mg loading dose with 500mg q12 4 hours later to maintain a trough level |
Recruiting |
Study Name: Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation Condition: Hematological Malignancies Date: 2016-07-04 Interventions: Biological: Allogeneic MPBC transplantation from matched related donor |
Completed |
Study Name: Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD Condition: Graft Versus Host Disease Date: 2016-06-28 Interventions: Biological: Mesenchymal Stem Cells Allogenic Human Bone Marrow Mesenchymal Stem Cells (ex-vivo expanded |
Recruiting |
Study Name: Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease Condition: Acute Graft Versus Host Disease in Skin Date: 2016-06-22 |
Recruiting |
Study Name: A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) Condition: Acute GVHD Date: 2016-06-08 Interventions: Drug: Sirolimus Sirolimus will |
Recruiting |
Study Name: Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections Condition: Allogeneic Stem Cell Transplant Acute Graft Versus Host Disease Date: 2016-06-01 Interventions: Drug: posaconazole iv versus oral Other Name: Noxafi |
Not yet recruiting |
Study Name: Modification of the Intestinal Microbiome by Diet Intervention to Mitigate Acute Graft-Versus-Host Disease Condition: Hematopoietic Stem Cell Transplantation Date: 2016-05-03 Interventions: Dietary Supplement: Bob's Red Mill® O |